Call Us (812) 401-7900
445 Cross Pointe Blvd. Suite 230
LATISSE™ (bimatoprost ophthalmic solution) 0.03%, approved by the U.S. Food and Drug Administration (FDA) in 2008, is a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. LATISSE™ is the first and only FDA-approved, science-based treatment to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes.
LATISSE™ users can expect to experience longer, fuller and darker eyelashes in as little as eight weeks, with full results in 16 weeks. To maintain effect, continued treatment with LATISSE™ is required. If use of LATISSE™ is discontinued, eyelashes will gradually return to where they were prior to treatment over a period of weeks to months (average eyelash hair cycle).
Great eyelashes don’t just happen overnight. That’s why it’s important to note that LATISSE™ (bimatoprost ophthalmic solution) 0.03% works gradually and remarkably — starting at 4 weeks with full results after 16 weeks. Once you begin treatment, you could start to see results in as little as 4 weeks, but you must continue applying the topical treatment each night and follow the directions for best results. Remember results are gradual over time.
LATISSE™ works from the inside out. As the treatment progresses, you’ll begin to see changes in length, thickness and darkness gradually. After week 16, you’ll see the full effect of LATISSE™ — and so will others.
Throughout clinical trials, some users did experience itchy eyes and eye redness. However, some users found that these irritations went away once they became accustomed to the product or began applying it properly. As with any prescription treatment, always consult with your doctor for information and proper usage of LATISSE™ solution.